DoD Melanoma, Survivorship Research Award
ID: 358948Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Melanoma Survivorship Research Award to support innovative research aimed at enhancing the health and well-being of melanoma survivors and their caregivers. This grant encourages collaborative research that integrates insights from melanoma consumers, with a focus on various aspects of survivorship, including psychological impacts, symptom management, and healthcare delivery challenges, while explicitly excluding studies limited to animal models or survival rates without quality of life considerations. The total estimated program funding is $2,320,000, with a maximum award amount of $725,000 per project over a three-year performance period. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due by October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Defense (DOD) announces the FY25 Melanoma Survivorship Research Award under the Defense Health Program to support innovative research aimed at improving the health and well-being of melanoma survivors and their caregivers. This program seeks to foster collaborative efforts that incorporate melanoma consumer insights into the research process. Applicants must submit a pre-application by September 10, 2025, followed by a full application due by October 1, 2025, targeting a maximum funding of $725,000 per award over a 3-year performance period. The program emphasizes research on various aspects of melanoma survivorship, including psychological impacts, symptom management, and healthcare delivery challenges. Strategies should address long-term effects of treatment and methods to improve quality of life while avoiding studies limited to animal models or survival rates without quality of life considerations. Key eligibility criteria include having a Principal Investigator from eligible organizations and mandatory collaboration with melanoma consumer partners. The application process involves detailed submission requirements, including budget formulations and clear evidence of support from collaborators. This funding opportunity reflects a commitment to enhancing melanoma care and aligns with military health considerations, aiming to bridge gaps in current research and treatment protocols.
    Similar Opportunities
    DoD Melanoma, Idea Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Melanoma Research Program Idea Award to support innovative and exploratory research related to melanoma. This grant aims to fund high-risk, potentially high-reward projects that focus on areas such as melanoma prevention, rare melanoma research, or survivorship impacts, with a maximum direct cost of $400,000 available for each project over a two-year period. The program is particularly significant for advancing melanoma detection, treatment, and survivorship, especially in the context of military health concerns. Interested applicants must submit a pre-application by June 30, 2025, followed by a full application due by October 1, 2025, with a total funding pool of approximately $5.76 million available for about nine awards. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Melanoma, Team Science Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), has announced the DoD Melanoma Team Science Award, a federal grant opportunity aimed at advancing melanoma research and patient care through multidisciplinary studies. This program requires collaboration among at least two to three Principal Investigators (PIs) from various institutions to address complex issues impacting patient outcomes, with a focus on innovative research areas such as prevention, interception, and survivorship related to melanoma. Approximately $16.8 million is available to fund around seven applications, with a direct cost cap of $1.5 million and a maximum project duration of three years. Interested applicants must submit a pre-application by June 30, 2025, followed by invited full applications due by October 1, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Melanoma, Melanoma Academy Scholar Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the FY25 Melanoma Academy Scholar Award to support early-career melanoma researchers. This grant aims to foster independent scientists who are within seven years of their initial faculty appointment by integrating them into a virtual collaborative academy that emphasizes mentorship and research development in melanoma. The program is particularly focused on three strategic research priorities: prevention and interception, studies on rare melanoma subtypes, and survivorship research, with a total funding allocation of approximately $1.76 million for two awards, each capped at $550,000 over a maximum period of three years. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due on October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Melanoma, Melanoma Academy Leadership Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Melanoma Academy Leadership Award, a federal grant aimed at establishing a Director and Deputy Director for the Melanoma Research Program's virtual academy. This initiative seeks to cultivate high-performing melanoma researchers by fostering mentorship and collaboration between established and early-career investigators, with a focus on enhancing patient outcomes and reducing the burden of melanoma. The total estimated funding for this opportunity is approximately $2.1 million, supporting one application with a direct cost cap of $1.3 million over a maximum performance period of four years. Interested applicants must submit a pre-application by October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further inquiries.
    DoD Melanoma, Focused Program Award – Rare Melanomas
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the DoD Melanoma, Focused Program Award aimed at advancing research on rare melanomas. This grant supports multidisciplinary teams to propose two to three complementary research projects centered around a common overarching question related to rare melanomas, with an emphasis on collaboration among Principal Investigators (PIs) from various institutions. The total funding available is $6.4 million, with approximately two awards expected, each providing up to $2 million over a maximum four-year period. Interested applicants must submit a pre-application by June 30, 2025, and, if invited, a full application by October 1, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Impact Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Cancer Research Program (PRCRP) Impact Award to support high-impact research aimed at improving clinical cancer care relevant to military health. This grant seeks mature research projects that demonstrate potential for near-term benefits in cancer treatment and patient outcomes, particularly focusing on specific cancer types such as bladder, blood, and brain cancers, while excluding melanoma and breast cancers. The program emphasizes the importance of preliminary data, collaboration with Department of Defense (DOD) and Veterans Affairs (VA) entities, and rigorous study designs to advance cancer detection and treatment for service members and their families. The estimated total program funding is $45.5 million, with individual awards capped at $1.4 million for single Principal Investigator applications and $1.75 million for partnering applications, over a maximum period of three years. Interested applicants must submit a pre-application by September 25, 2025, and can contact the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Peer Reviewed Cancer, Idea Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the fiscal year 2025 Peer Reviewed Cancer Research Program (PRCRP) Idea Award to support innovative cancer research that prioritizes military health. This grant aims to fund high-risk, high-reward proposals that focus on specific cancer types relevant to Service Members, Veterans, and their families, with an emphasis on introducing new paradigms in cancer care and addressing environmental exposure risks. With an estimated total program funding of approximately $14 million, the program anticipates awarding around 25 projects, each with a maximum funding limit of $560,000 for a duration of up to two years. Interested applicants must submit a pre-application by June 20, 2025, followed by a full application due by September 25, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Resource and Community Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Rare Cancers Research Program Resource and Community Development Award, with an estimated total funding of $5.6 million aimed at enhancing research resources and clinical data related to rare cancers. This grant seeks to address critical gaps in rare cancer research, including the lack of resources, communication strategies, and data-sharing infrastructure, while emphasizing the integration of patient advocates throughout the project lifecycle. Eligible applicants include both domestic and foreign non-profit and for-profit organizations, with applications due by October 6, 2025, following a pre-application deadline of July 1, 2025. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DoD Military Burn, Patient-Centered Research Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Military Burn Research Program's Patient-Centered Research Award (PCRA) to enhance clinical practices and interventions for burn victims in combat conditions. This grant opportunity, with an estimated total funding of $3.4 million, specifically supports clinical research involving human subjects, excluding preclinical studies, and aims to bridge the gap between research and practical application in austere environments. Proposals should focus on improving acute burn care practices, developing methods to prevent and treat cold injuries, and managing complications such as fluid resuscitation and inhalation injuries, with a strong emphasis on military health relevance and potential impact. Interested applicants must submit pre-applications by June 23, 2025, and full applications by September 8, 2025, with funding announcements expected by September 30, 2026. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Rare Cancers Research Program (RCRP) Idea Development Award for fiscal year 2025. This grant aims to support innovative research that explores new ideas and develops impactful strategies in the area of rare cancers, which are defined as those affecting six or fewer individuals per 100,000 annually in the U.S. Eligible applicants include various organizations, and the program encourages interdisciplinary collaboration among military, academic, and industry sectors to enhance health outcomes for military Service Members, Veterans, and the broader public. The total estimated program funding is $6,860,000, with a funding limit of $490,000 per application. Key deadlines include a pre-application due by July 1, 2025, and a full application by October 6, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.